PHF14

PHF14 is a chromatin-associated transcriptional repressor that reads unmodified histone H3 through a bipartite PHD1-ZnK-PHD2 (PZP) cassette and recruits silencing machinery to specific gene loci, thereby controlling mesenchymal cell proliferation, TGF-β signaling, and DNA damage responses. Its PZP domain engages H3 residues 1–34 via two distinct surfaces, with binding abolished by active histone marks at H3R2, T3, K4, R8, and K23, establishing PHF14 as a 'ground-state' chromatin reader (PMID:34365506). PHF14 directly represses PDGFRα transcription in mesenchymal cells—loss of PHF14 causes lethal lung interstitial hyperplasia in mice—and silences SMAD7 by recruiting DNMT3B for CpG methylation, thereby sustaining TGF-β signaling (PMID:22730381, PMID:37072414). PHF14 operates within the PHF5A–PHF14–HMG20A–RAI1 subcomplex associated with KMT2A, modulates Hippo/TEAD1-dependent transcription through its HMG20A partnership, regulates H3K4me3 at the Cdkn1a/p21 locus to promote germinal-center B cell proliferation, and contributes to BRCA2/RAD51 focus formation at DNA damage sites via interaction with KIF4A (PMID:37709746, PMID:36124662, PMID:33035772, PMID:35074497).

1. 2012 High

   Establishing PHF14 as a transcriptional repressor of PDGFRα answered how mesenchymal cell proliferation is kept in check: Phf14-null mice showed PDGFRα de-repression, hyperproliferative mesenchyme, and neonatal lethal lung disease.

   Evidence Gene-targeted Phf14-knockout mice with ChIP, transcription assays, and anti-PDGFRα antibody rescue

   PMID:22730381

   Open questions at the time

   • Mechanism by which PHF14 silences the PDGFRα promoter (cofactor recruitment) was unknown
   • Whether PHF14 represses PDGFRα in tissues beyond lung was untested
2. 2013 Medium

   Demonstrating that the major PHF14α isoform localizes to the nucleus, associates with chromatin during mitosis, and binds histones via PHD fingers established it as a bona fide chromatin-binding protein.

   Evidence Co-immunoprecipitation with histones, subcellular fractionation, live imaging in cultured cells

   PMID:23688586

   Open questions at the time

   • Histone binding shown by single Co-IP without reciprocal validation or domain mapping
   • Which histone modifications are recognized or excluded was not determined
3. 2017 High

   Identifying a TGF-β/SMAD3 → PHF14 → PDGFRα feedback loop in renal fibrosis revealed that PHF14 is itself transcriptionally induced by phospho-SMAD3 and functions as a self-limiting brake on fibrotic signaling.

   Evidence ChIP showing pSMAD3 binding at PHF14 promoter, PHF14-null kidney fibrosis model, SMAD3 inhibitor epistasis

   PMID:28045076

   Open questions at the time

   • Whether additional transcription factors cooperate with SMAD3 at the PHF14 promoter was not tested
   • The chromatin mechanism through which PHF14 represses PDGFRα remained undefined
4. 2019 Medium

   Linking PHF14 to hypoxia-responsive cell cycle control showed that PHF14 promotes proliferation partly by suppressing CDK inhibitors (p14ARF, p15, p16) and sustaining AKT-mTOR signaling.

   Evidence Pulsed-SILAC proteomics under hypoxia, PHF14 knockdown with cell cycle and signaling readouts, xenograft model

   PMID:31040906

   Open questions at the time

   • Whether PHF14 directly binds regulatory elements at INK4 loci or acts indirectly was not resolved
   • Relationship between histone reading function and AKT-mTOR pathway unclear
5. 2020 High

   Conditional knockout in germinal-center B cells showed PHF14 is required for GC formation and proliferation by regulating H3K4me3 levels at the Cdkn1a/p21 locus, providing the first direct link between PHF14 and a specific histone mark at a defined target gene.

   Evidence Conditional KO mouse (PHF14GCB), flow cytometry, ChIP for H3K4me3, SRBC/LCMV immunization

   PMID:33035772

   Open questions at the time

   • Whether PHF14 recruits a specific H3K4 methyltransferase or demethylase to Cdkn1a was not shown
   • Generalizability beyond GC B cells not established
6. 2021 High

   Solving the crystal structure of PHF14's PZP cassette bound to H3 revealed bipartite recognition of unmodified H3(1–34), defining PHF14 as a 'ground-state' histone reader negatively regulated by activating marks.

   Evidence X-ray crystallography, HDX-MS, ITC binding assays, systematic mutagenesis of H3 modification sites

   PMID:34365506

   Open questions at the time

   • How ground-state reading is translated into transcriptional repression (effector recruitment) was not structurally resolved
   • No nucleosome-level structure available
7. 2022 High

   Discovery of the PHF14–HMG20A coiled-coil complex and its modulation of Hippo/TEAD1 signaling and TGF-β-triggered EMT revealed a new transcriptional partnership beyond simple histone reading.

   Evidence AP-MS proteomics, reciprocal Co-IP, AlphaFold2 structural modeling, siRNA knockdown with transcriptomic and functional EMT readouts

   PMID:36124662

   Open questions at the time

   • Whether PHF14-HMG20A acts as a TEAD1 coactivator or corepressor at specific genomic loci not determined
   • Structural basis of TEAD1 interaction undefined
8. 2022 Medium

   Demonstrating that PHF14 interacts with KIF4A and is required for BRCA2/RAD51 foci at DNA damage sites placed PHF14 in the DNA damage response, expanding its function beyond transcriptional control.

   Evidence Co-immunoprecipitation (PHF14-KIF4A), immunofluorescence for BRCA2/RAD51 foci, siRNA knockdown, ATR-CHK1-H2AX western blots

   PMID:35074497

   Open questions at the time

   • KIF4A interaction shown by single Co-IP without reciprocal validation
   • Whether PHF14 is recruited to damage sites directly or via KIF4A not resolved
   • No separation of DNA repair defect from cell cycle effects of PHF14 loss
9. 2022 Medium

   Confirming PDGFRα de-repression in neuroblastoma and mesenchymal cells upon PHF14 KO, and showing that this sensitizes cells to Sunitinib, validated the PHF14–PDGFRα axis as a potential therapeutic vulnerability.

   Evidence CRISPR/Cas9 KO and shRNA knockdown, RT-PCR/western blot, Sunitinib drug sensitivity assay, xenograft

   PMID:36359362

   Open questions at the time

   • Whether PHF14 loss universally sensitizes to PDGFR inhibitors across tumor types not tested
   • Mechanism by which PHF14 represses PDGFRα promoter still indirect
10. 2023 High

    Showing that PHF14 recruits DNMT3B to methylate CpG sites at the SMAD7 locus provided the first mechanistic explanation for how PHF14 achieves transcriptional silencing—through DNA methylation—and linked this to TGF-β-driven metastasis.

    Evidence Reciprocal Co-IP, ChIP, bisulfite sequencing at SMAD7, DNMT3B knockdown epistasis, in vivo metastasis assays

    PMID:37072414

    Open questions at the time

    • Whether DNMT3B recruitment is the general silencing mechanism at other PHF14 targets (e.g. PDGFRα) is unknown
    • How the PZP histone-reading activity coordinates with DNA CpG recognition not clarified
11. 2023 High

    Identification of PHF14 as a stable subunit of the PHF5A–PHF14–HMG20A–RAI1 subcomplex associated with KMT2A positioned PHF14 within a defined chromatin-remodeling machine regulating cancer stem cell self-renewal.

    Evidence Reciprocal Co-IP, proteomic mass spectrometry, KMT2A-WDR5 inhibitor functional assay, in vivo tumorigenicity

    PMID:37709746

    Open questions at the time

    • Stoichiometry and architecture of the subcomplex not structurally defined
    • Direct contribution of PHF14 versus other subunits to KMT2A activity not dissected
12. 2024 Medium

    Showing that SP4 directly binds and activates the PHF14 promoter placed SP4 upstream of PHF14 in esophageal squamous cell carcinoma and linked PHF14 to Wnt/β-catenin pathway activation.

    Evidence ChIP assay, luciferase reporter, siRNA/overexpression rescue, western blot for β-catenin pathway

    PMID:37768180

    Open questions at the time

    • Whether PHF14 directly regulates Wnt pathway gene promoters or acts indirectly not resolved
    • Relationship between PHF14 histone reading and Wnt activation unclear

• How PHF14's ground-state histone reading, DNMT3B-mediated DNA methylation activity, and participation in the KMT2A-associated complex are coordinated at individual genomic loci—and whether they represent context-dependent or integrated mechanisms—remains the central unresolved question.
• No genome-wide map of PHF14 occupancy correlated with histone and DNA methylation states
• No reconstituted system demonstrating coupled histone reading and DNMT3B recruitment
• Role of PHF14 in neurodevelopment suggested by complex membership but not tested with primary experimental data